J&J lifts profit and sales forecasts, beats Wall Street expectations
By Patrick Wingrove and Bhanvi Satija (Reuters) – Johnson & Johnson (NYSE:JNJ) raised its 2024 profit and sales forecasts on Tuesday after reporting strong sales of oncology drugs and quarterly…